Multiplicity of garlic health effects and Alzheimer's disease

Journal of Nutrition, Health and Aging

Volumn 9, Issue 6, 2005, Pages 421-432

  Chauhan, Neelima B ^a,b  

^a JESSE BROWN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apoptosis; Beta amyloid; DADS; HMG CoA Reductase inhibitors; Learning and memory; Neuroinflammation; Oxidative damage; SAC

Indexed keywords

GARLIC EXTRACT;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN FUNCTION; CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DNA DAMAGE; GARLIC; HEART PROTECTION; HUMAN; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STROKE;

ALLIUM SATIVUM;

EID: 29144508430     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. http://www.who.int/bulletin/en/. Traditional Herbal Medicine. Accessed on September 27, 2004.
2. Block E., The chemistry of garlic and onions, Sci. Amer., 1985, 252:114-119.
3. www.floridavediccollege.edu. The History of Ayurveda. Accessed on August 31, 2004.
4. Rahman K., Historical perspective on garlic and cardiovascular disease, J. Nutr., 2001, 131(3s):977S-979S.
5. Woodward P.W., Garlic and Friends: The History, Growth and Edible Alliums, 1996, 2-22.
6. Rivlin R.S., Historical perspective on the use of garlic, J. Nutr., 2001:131, 951S-954S.
7. Moyers S., Garlic in Health, In: History and World Cuisine. Suncoast Press, St. Petersburg, FL, 1996, 1-36.
8. Kahn G., History of Garlic, In: Koch HP and Lawson LD, eds. Garlic, The Science and Therapeutic Application of Allium sativum L. and related species, Williams and Wilkins, NY, 1996, 25-36.
9. Borek C., Anti-oxidant effects of aged garlic extract, J. Nutr. 2001, 131:1010S-1015S.
10. Green O.C. III and Polydoris N.G., Garlic, Cancer and Heart Disease, GN Communications, Chicago, IL 1993.
11. Amagase H., Petesch B.L., Matsuura H., Kasuga S., Itakura Y., Intake of garlic and its bioactive components, J. Nutr., 2001, 131(3s):955S-962S.
12. Fenwick G.R., Hanley A.B., The genus Allium. Part 2, Crit. Rev. Food. Sci. Nutr., 1985, 22(4):273-377.
13. Freeman F. and Kodera Y., Garlic Chemistry: stability of S-(2-propyenyl)-2-propene-1-sulfinothionate (allicin) in blood, solvents, and simulated physiological fluids, J. Agricul. Food Chem., 1995, 43:2332-2338.
14. Liu L. and Yeh Y., Organosulfur compounds of garlic inhibit fatty acid biosynthesis in cultured rat hepatocytes, FASEB J., 1999, 13:A556.
15. Lawson L.D., Bioactive organosulfur compounds of garlic and garlic products. In: Kinghom AD and Balandrin MF, eds. ACS Symposium Series 534, Human Medical Agents from Plants, American Chemical Society, Washington, DC, 1993, 306-330.
16. Imai J., Ide N., Nagae S., Moriguchi T., Matsuura H., Itakura Y., Antioxidant and radical scavenging effects of aged garlic extract and its constituents, Planta Med., 1994, 60(5):417-420.
17. Iberl B., Winkler G. and Knobloch K., Products of allicin transformation: ajoenes and dithiins, characterization and their deremination by HPLC, Planta Med., 1990, 56:202-211.
18. Neil A., Silagy C., Lancaster T., Hodgeman J., Vos K., Moore J., Jones J., Cahill J. and Fowler G., Garlic powder in the treatment of moderate hyperlipidemia: a controlled trial and meta-analyses, J.R. College of Physicians, London 1996, 30:329-334.
19. Isaacsohn J.L., Moser M., Stein E.A., Dudley K., Davey J.A., Liskov E., Black H.R., Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial, Arch. Intern Med., 1998, 158(11):1189-1194.
20. Yan X., Wang Z. and Barlow P., Quantitative estimation of garlic oil content in garlic oil based health products. Food Chemistry, 1992, 45:135-139.
21. Takasu J., Uykimpang R., Sunga M., Amagase H., Niihara Y., Aged garlic extract therapy for sickle cell anemia patients, BMC Blood Disord., 2002, 2(1):3.
22. Amagase H., Intake of garlic and its components, Nutritional and Health benefits of Garlic as a supplement Conference, New Port Beach, CA, 1998, 4.
23. Ide N., Lau B.H., Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury, J. Pharm. Pharmacol., 1997, 49(9):908-911.
24. O'Brien J. and Gillies D.G., Product of the Maillard reaction in aged garlic extract are anti-oxidants. Nutritional and Health benefits of Garlic as a supplement Conference, New Port Beach, CA, 1998, 66.
25. Mattsuura H., Ushiroguchi T., Itakura Y., Hayashi N. and Fuwa T., A furostanol glycoside from garlic, bulbs of Allium sativum L., Chem. Pharmacol. Bull., 1988, 36:3659-3663.
26. Kaku H., Goldstein I.J., Van Damme E.J., Peumans W.J., New mannose-specific lectins from garlic (Allium sativum) and ramsons (Allium ursinum) bulbs, Carbohydr. Res., 1992, 229(2):347-353.
27. Borek C., Molecular mechanisms in cancer induction and prevention, Environ. Health Perspect, 1993, 101 Suppl 3:237-245.
28. Horie T., Murayama T., Mishima T., Itoh F., Minamide Y., Fuwa T., Awazu S., Protection of liver microsomal membranes from lipid peroxidation by garlic extract, Planta Med., 1989, 55(6):506-508.
29. Witztum J.L., Role of oxidised low density lipoprotein in atherogenesis, Br. Heart J., 1993, 69(1 Suppl):S12-18.
30. Gutteridge J.M., Free radicals in disease processes: a compilation of cause and consequence, Free Radic. Res. Commun., 1993, 19(3):141-158.
31. Liu J., Lin X.Y. and Milner J.A., Dietary garlic powder increases glutathione content and glutathione-S-transferase activity in rat liver and mammary tissues, FASEB J., 1992, 6:A3230.
32. Yamasaki T., Li L. and Lau B., Garlic compounds protect vascular endothelial cells from hydrogen peroxide-induced oxidant injury, Phytother. Res., 1994, 8:408-412.
33. Chen L., Hong J.Y., So E., Hussin A.H., Cheng W.F., Yang C.S., Decrease of hepatic catalase level by treatment with diallyl sulfide and garlic homogenates in rats and mice, J. Biochem. Mol. Toxicol., 1999, 13(3-4):127-134.
34. Wei Z. and Lau B.H.S., Garlic inhibits free radical generation and augments antioxidant enzyme activity in vascular endothelial cells, Nutr. Res., 1998, 18:61-70.
35. Numagami Y., Sato S., Ohnishi S.T. Attenuation of rat ischemic brain damage by aged garlic extracts: a possible protecting mechanism as antioxidants, Neurochem. Int., 1996, 29(2):135-143.
36. Geng Z., Kong Y., Lau B.H., S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells, Free Radic. Biol. Med., 1997, 23(2):345-350.
37. Ide N., Lau B.H., S-allylcysteine attenuates oxidative stress in endothelial cells, Drug Dev., Ind. Pharm., 1999, 25(5):619-624.
38. Siegers C.P., Robke A., Pentz R., Effects of garlic preparations on superoxide production by phorbol ester activated granulocytes, Phytomedicine, 1999, 6(1):13-16.
39. Prasad K., Mantha S.V., Kalra J., Lee P., Prevention of Hypercholesterolemic Atherosclerosis by Garlic, an Antixoidant, J. Cardiovasc. Pharmacol. Ther., 1997, 2(4): 309-320.
40. Prasad K., Laxdal V.A., Yu M., Raney B.L., Antioxidant activity of allicin, an active principle in garlic, Mol. Cell Biochem., 1995, 148(2):183-189.
41. Rabinkov A., Miron T., Konstantinovski L., Wilchek M., Mirelman D., Weiner L., The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins, Biochim. Biophys. Acta., 1998, 1379(2):233-244.
42. Rabinkov A., Miron T., Mirelman D., Wilchek M., Glozman S., Yavin E., Weiner L., S-Allylmercaptoglutathione: the reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties, Biochim. Biophys. Acta, 2000, 1499(1-2):144-153.
43. Kim K.M., Chun S.B., Koo M.S., Choi W.J., Kim T.W., Kwon Y.G., Chung H.T., Billiar T.R., Kim Y.M., Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine, Free Radic. Biol. Med., 2001, 30(7):747-756.
44. Schwartz I.F., Hershkovitz R., Iaina A., Gnessin E., Wollman Y., Chernichowski T., Blum M., Levo Y., Schwartz D., Garlic attenuates nitric oxide production in rat cardiac myocytes through inhibition of inducible nitric oxide synthase and the arginine transporter CAT-2 (cationic amino acid transporter-2), Clin. Sci. (Lond), 2002, 102(5):487-493.
45. Ohsumi C., Hayashi T., The oligosaccharide units of the xyloglucans in the cell walls of bulbs of onion, garlic and their hybrid, Plant Cell Physiol., 1994, 35(6):963-967.
46. Ryu K., Ide N., Matsuura H., Itakura Y., N alpha-(1-deoxy-D-fructos-1-yl) -L-arginine, an antioxidant compound identified in aged garlic extract, J. Nutr., 2001, 131(3s):972S-976S.
47. Kalantari H., Salehi M., The protective effect of garlic oil on hepatotoxicity induced by acetaminophen in mice and comparison with N-acetylcysteine, Saudi Med. J., 2001, 22(12):1080-1084.
48. Mostafa M.G., Mima T., Ohnishi S.T., Mori K., S-allylcysteine ameliorates doxorubicin toxicity in the heart and liver in mice, Planta Med., 2000, 66(2):148-151.
49. Helen A., Krishnakumar K., Vijayammal P.L., Augusti K.T., A comparative study of antioxidants S-allyl cysteine sulfoxide and vitamin E on the damages induced by nicotine in rats. Pharmacology. 2003;67(3):113-117.
50. Hsu C.C., Huang C.N., Hung Y.C., Yin M.C., Five cysteine-containing compounds have antioxidative activity in Balb/cA mice, J. Nutr., 2004, 134(1):149-152.
51. Borek C., Anti-oxidants and cancer, Sci. Med. 1997, 4:51-62.
52. Yamasaki T., Teel R.W., Lau B.H., Effect of allixin, a phytoalexin produced by garlic, on mutagenesis, DNA-binding and metabolism of aflatoxin B1, Cancer Lett., 1991, 59(2):89-94.
53. Nishino H., Nishino A., Takayasu A., Iwashima Y., Itakura Y., Kodera Y., Matsuura H. and Fuwa T., Anti-tumor promoting activity of allixin, a stress compound produced by garlic. Cancer J., 1990, 3:20-21.
54. Takeyama H., Hoon D.S., Saxton R.E., Motion D.L., Irie R.F., Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine, Oncology, 1993, 50(1):63-69.
55. Liu J.Z., Schaffer E.M., Pegg A.E. and Milner J.A., Dietary garlic inhibits mammary earcinogenesis induced by n-methylnitrosourea, Exp. Biol., 1995, 95.
56. Nishino H., Iwashima A., Itakura Y., Matsuura H., Fuwa T., Antitumor-promoting activity of garlic extracts, Oncology, 1989, 46(4):277-280.
57. Amagase H., Schaffer E.M., Milner J.A., Dietary components modify the ability of garlic to suppress 7,12-dimethylbenz(a)anthracene-induced mammary DNA adducts, J. Nutr., 1996, 126(4):817-824.
58. Qureshi A.A., Lehmann J.W., Peterson D.M., Amaranth and its oil inhibit cholesterol biosynthesis in 6-week-old female chickens, J. Nutr., 1996, 126(8):1972-1978.
59. Gebhardt R., Beck H., Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures, Lipids, 1996, 31(12):1269-1276.
60. Milner J.A. Garlic: its anticarcinogenic and antitumorigenic properties, Nutr. Rev., 1996, 54(11 Pt 2):S82-66.
61. Song K., Milner J.A., Heating garlic inhibits its ability to suppress 7, 12-dimethylbenz(a)anthracene-induced DNA adduct formation in rat mammary tissue, J. Nutr., 1999, 129(3):657-661.
62. Wargovich M.J., Colon cancer chemoprevention with ginseng and other botanicals, J. Korean Med. Sci., 2001, 16 Suppl:S81-86.
63. Kamat A.M., Lamm D.L., Chemoprevention of bladder cancer, Urol. Clin. North Am., 2002, 29(1):157-168.
64. Bottone F.G. Jr, Baek S.J., Nixon J.B., Eling T.E., Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells, J. Nutr., 2002, 132(4):773-778.
65. Lea M.A., Rasheed M., Randolph V.M., Khan F., Shareef A., desBordes C., Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine, Nutr. Cancer, 2002, 43(1):90-102.
66. Hodge G., Hodge S., Han P., Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease, Cytometry, 2002, 48(4):209-215.
67. Dirsch V.M., Vollmar A.M., Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? Biochem. Pharmacol., 2001, 61(5):587-593.
68. Fernandez-Vizarra P., Fernandez A.P., Castro-Blanco S., Encinas J.M., Serrano J., Bentura M.L., Munoz P., Martinez-Murillo R., Rodrigo J., Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease, Neurobiol. Dis., 2004, 15(2):287-305.
69. Dirsch V.M., Kiemer A.K., Wagner H., Vollmar A.M., Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide synthase, Atherosclerosis, 1998, 139(2):333-339.
70. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A., Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. U. S. A., 1990, 87(4):1620-1624.
71. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A., Superoxide and peroxynitrite in atherosclerosis, Proc. Natl. Acad. Sci. U. S. A., 1994, 91(3):1044-1048.
72. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J., Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism., Proc. Natl. Acad. Sci. U. S. A., 1998, 95(10):5795-5800.
73. Keiss H.P., Dirsch V.M., Hartung T., Haffner T., Trueman L., Auger J., Kahane R., Vollmar A.M., Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-kappaB activity, J. Nutr., 2003, 133(7):2171-2175.
74. Morihara N., Sumioka I., Moriguchi T., Uda N., Kyo E, Aged garlic extract enhances production of nitric oxide, Life Sci., 2002, 71(5):509-517.
75. Amagase H., Anti-oxidant and radical scavenging effects of aged garlic extract and its constituents, Antioxidants and Diseases, 6th congress on Clinical Nutrition. Banf, Alberta, Canada, 1997.
76. Efendy J.L., Simmons D.L., Campbell G.R., Campbell J.H., The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis, Atherosclerosis, 1997, 132(1):37-42.
77. Abramovitz D., Gavri S., Harats D., Levkovitz H., Mirelman D., Miron T., Eilat-Adar S., Rabinkov A., Wilchek M., Eldar M., Vered Z., Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet, Coron. Artery Dis., 1999, 10(7):515-519.
78. Campbell J.H., Efendy J.L., Smith N.J., Campbell G.R., Molecular basis by which garlic suppresses atherosclerosis, J. Nutr., 2001, 131(3s):1006S-1009S.
79. Shimokawa H., Primary endothelial dysfunction: atherosclerosis, J. Mol. Cell Cardiol., 1999, 31(1):23-37.
80. Tsutsui M., Neuronal nitric oxide synthase as a novel anti-atherogenic factor, J. Atheroscler. Thromb., 2004, 11(2):41-48.
81. Kalinowski L., Malinski T., Endothelial NADH/NADPH-dependent enzymatic sources of superoxide production: relationship to endothelial dysfunction, Acta Biochim. Pol., 2004, 51(2):459-469.
82. Ignarro L.J., Napoli C., Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis, Curr. Atheroscler. Rep., 2004, 6(4):281-287.
83. Mason R.P., Walter M.F., Jacob R.F., Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress, Circulation, 2004, 109(21 Suppl 1):II34-1141.
84. Srivastava K.C., Tyagi O.D., Effects of a garlic-derived principle (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets, Prostaglandins Leukot. Essent. Fatty Acids, 1993, 49(2):587-595.
85. Melzig M.F., Krause E., Franke S., Inhibition of adenosine deaminase activity of aortic endothelial cells by extracts of garlic (Allium sativum L.), Pharmazie, 1995, 50(5)359-361.
86. Agarwal K.C., Therapeutic actions of garlic constituents, Med. Res. Rev., 1996, 16(1):111-124.
87. Ali M., Bordia T., Mustafa T., Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation, Prostaglandins Leukot. Essent. Fatty Acids, 1999, 60(1):43-47.
88. Ali M., Al-Qattan K.K., Al-Enezi F., Khanafer R.M., Mustafa T., Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet, Prostaglandins Leukot. Essent. Fatty Acids, 2000, 62(4):253-259.
89. McMahon F.G., Vargas R., Can garlic lower blood pressure? A pilot study. Pharmacotherapy, 1993, 13(4):406-407.
90. Steiner M., Li W., Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions, J. Nutr., 2001, 131(3s):980S-984S.
91. Rahman K., Garlic and aging: new insights into an old remedy, Ageing Res. Rev., 2003, 2(1):39-56.
92. Rahman K., Billington D., Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans, J. Nutr., 2000, 130(11):2662-2665.
93. Chang M.L., Johnson M.A., Effect of garlic on carbohydrate metabolism and lipid synthesis in rats, J. Nutr., 1980, 110(5):931-936.
94. Chi M.S., Effects of garlic products on lipid metabolism in cholesterol-fed rats (41494), Proc. Soc. Exp. Biol. Med., 1982, 171(2):174-178.
95. Yeh Y.Y., Yeh S.M., Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis, Lipids, 1994, 29(3):189-193.
96. Mathew B.C., Daniel R.S., Augusti K.T., Hypolipidemic effect of garlic protein substituted for casein in diet of rats compared to those of garlic oil, Indian J. Exp. Biol., 1996, 34(4):337-340.
97. Bordia A., Arora S.K., Kothari L.K., Jain K.C., Rathore B.S., Rathore A.S., Dube M.K., Bhu N., The protective action of essential oils of onion and garlic in cholesterol-fed rabbits, Atherosclerosis, 1975, 22(1):103-109.
98. Bordia A., Verma S.K., Effect of garlic feeding on regression of experimental atherosclerosis in rabbits, Artery, 1980, 7(5):428-437.
99. Qureshi A.A., Abuirmeileh N., Din Z.Z., Elson C.E., Burger W.C., Inhibition of cholesterol and fatty acid biosynthesis in liver enzymes and chicken hepatocytes by polar fractions of garlic, Lipids, 1983, 18(5):343-348.
100. Qureshi A.A., Crenshaw T.D., Abuirmeileh N., Peterson D.M., Elson C.E., Influence of minor plant constituents on porcine hepatic lipid metabolism. Impact on serum lipids, Atherosclerosis, 1987, 64(2-3):109-115.
101. Yeh Y.Y., Liu L., Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies, J. Nutr., 2001, 131(3s):989S-9893S.
102. Slowing K., Ganado P., Sanz M., Ruiz E., Tejerina T., Study of garlic extracts and fractions on cholesterol plasma levels and vascular reactivity in cholesterol-fed rats, J. Nutr., 2001, 131(3s):994S-999S.
103. Gebhardt R., Inhibition of cholesterol biosynthesis by a water-soluble garlic extract in primary cultures of rat hepatocytes, Arzneimittelforschung, 1991, 41(8):800-804.
104. Gebhardt R., Beck H., Wagner K.G., Inhibition of cholesterol biosynthesis by allicin and ajoene in rat hepatocytes and HepG2 cells, Biochim. Biophys. Acta, 1994, 1213(1):57-62.
105. Mattsuura H., Saponins in garlic as modifiers of the risk of cardiovascular disease, J. Nutr., 131(3s):1000S-10005S.
106. Arora R.C., Arora S., Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia, Atherosclerosis, 1981, 39(4):447-452.
107. Bordia A., Effect of garlic on blood lipids in patients with coronary heart disease, Am. J. Clin. Nutr., 1981, 34(10):2100-2103.
108. Lau B.H.S., Lam F. and Wang-Chen R., Effect of an odor-modified garlic preparation on blood lipids, Nutr. Res., 1987, 7:139-149.
109. Jain A.K., Vargas R., Gotzkowsky S., McMahon F.G., Can garlic reduce levels of serum lipids? A controlled clinical study, Am. J. Med., 1993, 94(6):632-635.
110. Steiner M., Khan A.H., Holbert D., Lin R.L. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids, Am. J. Clin. Nutr., 1996, 64(6):866-870.
111. Warshatsky S., Kamer R.S., Sivak S.L., Effect of garlic on total serum cholesterol, A meta-analysis, Ann. Intern. Med., 1993, 119(7 Pt 1):599-605.
112. Silagy C., Neil A., Garlic as a lipid lowering agent - a meta-analysis, J R Coll Physicians Lond., 1994, 28(1):39-45.
113. Akama K.T., Van Eldik L.J. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism, J. Biol. Chem., 2000, 275(11):7918-7924.
114. Nishiyama N., Moriguchi T., Morihara N., Saito H., Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice, J. Nutr., 2001, 131(3s):1093S-1095S.
115. Jackson R., McNeil B., Taylor C., Holl G., Ruff D., Gwebu E.T., Effect of aged garlic extract on caspase-3 activity, in vitro, Nutr. Neurosci., 2002, 5(4):287-290.
116. Numagami Y., Ohnishi S.T., S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia, J. Nutr., 2001, 131(3s):1100S-1105S.
117. Omkumar R.V., Kadam S.M., Banerji A., Ramasarma T., On the involvement of intramolecular protein disulfide in the irreversible inactivation of 3-hydroxy-3-methylglutaryl-CoA reductase by diallyl disulfide, Biochim. Biophys. Acta, 1993, 1164(1):108-112.
118. Numagami Y., Zubrow A.B., Mishra O.P., Delivoria-Papadopoulos M., Lipid free radical generation and brain cell membrane alteration following nitric oxide synthase inhibition during cerebral hypoxia in the newborn piglet, J. Neurochem., 1997, 69(4):1542-1547.
119. Gupta R., Singh M., Sharma A., Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury, Pharmacol. Res., 2003, 48(2):209-215.
120. Griffin B., Selassie M., Gwebu E.T., Aged garlic extract suppresses lipid peroxidation induced by beta-amyloid in PC12 cells, In Vitro Cell Dev. Biol. Anim., 2000, 36(5):279-280.
121. Peng Q., Buz'Zard A.R., Lau B.H., Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro, Med. Sci. Monit., 2002, 8(8):BR328-337.
122. Ito Y., Kosuge Y., Sakikubo T., Horie K., Ishikawa N., Obokata N., Yokohama E., Yamashina K., Yamamoto M., Saito H., Arakawa M., Ishige K., Protective effect of S-allyl-L-cysteine, a garlic compound, on amyloid beta-protein-induced cell death in nerve growth factor-differentiated PC12 cells, Neurosci. Res., 2003, 46(1):119-125.
123. Chauhan N.B., Siegel G.J. and Feinstein D.L., Propentofylline attenuates tau phosphorylation in Alzheimer's Swedish mutant model Tg2576, Neuropharmacology, 2004, in press.
124. Moriguchi T., Matsuura H., Itakura Y., Katsuki H., Saito H., Nishiyama N., Allixin, a phytoalexin produced by garlic, and its analogues as novel exogenous substances with neurotrophic activity, Life Sci., 1997, 61(14):1413-1420.
125. Moriguchi T., Matsuura H., Kodera Y., Itakura Y., Katsuki H., Saito H., Nishiyama N., Neurotrophic activity of organosulfur compounds having a thioallyl group on cultured rat hippocampal neurons, Neurochem. Res., 1997, 22(12):1449-1452.
126. Moriguchi T., Saito H., Nishiyama N., Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model, Clin. Exp. Pharmacol. Physiol., 1997, 24(3-4):235-242.
127. Simons M., Keller P., Dichgans J., Schulz J.B., Cholesterol and Alzheimer's disease: is there a link? Neurology, 2001, 57(6):1089-1093.
128. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K., Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons, Proc. Natl. Acad. Sci. U. S. A., 1998, 95(11):6460-6464.
129. Chauhan N.B., Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease, J. Lipid Res., 2003, 44(11):2019-2029.
130. Simons K., Ikonen E., Functional rafts in cell membranes, Nature, 1997, 387(6633):569-572.
131. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T. Jr, Kosik K.S., A detergent-insoluble membrane compartment contains A beta in vivo, Nat. Med. 1998, 4(6):730-734.
132. Fassbender K., Stroick M., Bertsch T., Ragoschke A., Kuehl S., Walter S., Walter J., Brechtel K., Muehlhauser F., Von Bergmann K., Lutjohann D., Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide, Neurology, 2002, 59(8):1257-1258.
133. Chauhan N.B., Siegel G.J. and Feinstein D.L., Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain, Neurochem. Res., 2004, 29(10):1897-1911.
134. Chauhan N.B., Anti-Amyloidogenic Effect of Allium sativum in Alzheimer's Transgenic Model Tg2576, J. Herb. Pharmcother., 2003, 3(1):93-105.
135. Chauhan N.B., Effect of aged garlic extract on amyloidogenesis and tau phosphorylation in Tg2576 mouse model of AD, Soc. Neurosci. Abstr., 2004, Prog. No. 674.17.
136. Moriguchi T., Takashina K., Chu P.J., Saito H., Nishiyama N., Prolongation of life span and improved learning in the senescence accelerated mouse produced by aged garlic extract, Biol. Pharm. Bull., 1994, 17(12):1589-1594.
137. Moriguchi T., Saito H., Nishiyama N., Aged garlic extract prolongs longevity and improves spatial memory deficit in senescence-accelerated mouse, Biol. Pharm. Bull., 1996, 19(2):305-307.
138. Nishiyama N., Moriguchi T., Saito H., Beneficial effects of aged garlic extract on learning and memory impairment in the senescence-accelerated mouse, Exp. Gerontol., 1997, 32(1-2):149-160.
139. Sumiyoshi H., [New pharmacological activities of garlic and its constituents], Nippon Yakurigaku Zasshi, 1997, 110 Suppl 1:93P-97P.
140. Zhang Y., Moriguchi T., Saito H., Nishiyama N., Functional relationship between age-related immunodeficiency and learning deterioration, Eur. J. Neurosci., 1998, 10(12):3869-3875.
141. Yamada N., Hattori A., Hayashi T., Nishikawa T., Fukuda H., Fujino T., Improvement of scopolamine-induced memory impairment by Z-ajoene in the water maze in mice, Pharmacol. Biochem. Behav., 2004, 78(4):787-791.
142. Alzheimer's Data Base, Nidus Information Services, 2002. FDA approved Clinical Drug trials in Alzheimer's treatment.
143. Buxbaum J.D., Cullen E.I., Friedhoff L.T., Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients, Front Biosci., 2002, 7:a50-59.
144. Scott H.D., Laake K., Statins for the prevention of Alzheimer's disease, Cochrane Database Syst. Rev., 2001, (4):CD003160.
145. Kwon K.B., Yoo S.J., Ryu D.G., Yang J.Y., Rho H.W., Kim J.S., Park J.W., Kim H.R., Park B.H., Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells, Biochem. Pharmacol., 2002, 63(1):41-47.